Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients

The value of performing follow-up PET/CT imaging more than 6 mo after the conclusion of therapy—either as a routine practice or because of clinically suspected recurrence—is not well established. The purpose of this study was to evaluate the added value of follow-up PET/CT to the clinical assessment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nuclear medicine (1978) 2014-04, Vol.55 (7), p.1062-1068
Hauptverfasser: Antoniou, Alexander J., Marcus, Charles, Tahari, Abdel K., Wahl, Richard L., Subramaniam, Rathan M.
Format: Artikel
Sprache:eng ; jpn
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1068
container_issue 7
container_start_page 1062
container_title The Journal of nuclear medicine (1978)
container_volume 55
creator Antoniou, Alexander J.
Marcus, Charles
Tahari, Abdel K.
Wahl, Richard L.
Subramaniam, Rathan M.
description The value of performing follow-up PET/CT imaging more than 6 mo after the conclusion of therapy—either as a routine practice or because of clinically suspected recurrence—is not well established. The purpose of this study was to evaluate the added value of follow-up PET/CT to the clinical assessment and survival outcome of lung cancer patients.
doi_str_mv 10.2967/jnumed.113.136770
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4324379</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4324379</sourcerecordid><originalsourceid>FETCH-LOGICAL-j1640-1495ea891ebcad486d6955e1fed49691ff8d81c3bd23d973a047e20dac97580b3</originalsourceid><addsrcrecordid>eNpVkMtKAzEYhYMotlYfwF1eIG3-yX0jyNhWodCCdT1kJpmakmbKTGfEt7deNq7O4uOcDw5C90CnmZFqtk_9wbspAJsCk0rRCzQGwQQRUqpLNKYggQhBxQjddN2eUiq11tdolHGlVGboGL0tmhibD9IfcdPi174dfIjRpspj0AuyeFrizXw7y7fYJvfDw2AjXvenqjl4HBJe9WmH8-9Gizf2FHw6dbfoqrax83d_OTl75tv8mazWy5f8cUX2IDklwI3wVhvwZWUd19JJI4SH2jtupIG61k5DxUqXMWcUs5Qrn1FnK6OEpiWboIff3WNfnp-ozu7WxuLYhoNtP4vGhuI_SeG92DVDwVnGmTLsCzZ0X3U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Antoniou, Alexander J. ; Marcus, Charles ; Tahari, Abdel K. ; Wahl, Richard L. ; Subramaniam, Rathan M.</creator><creatorcontrib>Antoniou, Alexander J. ; Marcus, Charles ; Tahari, Abdel K. ; Wahl, Richard L. ; Subramaniam, Rathan M.</creatorcontrib><description>The value of performing follow-up PET/CT imaging more than 6 mo after the conclusion of therapy—either as a routine practice or because of clinically suspected recurrence—is not well established. The purpose of this study was to evaluate the added value of follow-up PET/CT to the clinical assessment and survival outcome of lung cancer patients.</description><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><identifier>DOI: 10.2967/jnumed.113.136770</identifier><identifier>PMID: 24777290</identifier><language>eng ; jpn</language><ispartof>The Journal of nuclear medicine (1978), 2014-04, Vol.55 (7), p.1062-1068</ispartof><rights>COPYRIGHT © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Antoniou, Alexander J.</creatorcontrib><creatorcontrib>Marcus, Charles</creatorcontrib><creatorcontrib>Tahari, Abdel K.</creatorcontrib><creatorcontrib>Wahl, Richard L.</creatorcontrib><creatorcontrib>Subramaniam, Rathan M.</creatorcontrib><title>Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients</title><title>The Journal of nuclear medicine (1978)</title><description>The value of performing follow-up PET/CT imaging more than 6 mo after the conclusion of therapy—either as a routine practice or because of clinically suspected recurrence—is not well established. The purpose of this study was to evaluate the added value of follow-up PET/CT to the clinical assessment and survival outcome of lung cancer patients.</description><issn>0161-5505</issn><issn>1535-5667</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkMtKAzEYhYMotlYfwF1eIG3-yX0jyNhWodCCdT1kJpmakmbKTGfEt7deNq7O4uOcDw5C90CnmZFqtk_9wbspAJsCk0rRCzQGwQQRUqpLNKYggQhBxQjddN2eUiq11tdolHGlVGboGL0tmhibD9IfcdPi174dfIjRpspj0AuyeFrizXw7y7fYJvfDw2AjXvenqjl4HBJe9WmH8-9Gizf2FHw6dbfoqrax83d_OTl75tv8mazWy5f8cUX2IDklwI3wVhvwZWUd19JJI4SH2jtupIG61k5DxUqXMWcUs5Qrn1FnK6OEpiWboIff3WNfnp-ozu7WxuLYhoNtP4vGhuI_SeG92DVDwVnGmTLsCzZ0X3U</recordid><startdate>20140428</startdate><enddate>20140428</enddate><creator>Antoniou, Alexander J.</creator><creator>Marcus, Charles</creator><creator>Tahari, Abdel K.</creator><creator>Wahl, Richard L.</creator><creator>Subramaniam, Rathan M.</creator><scope>5PM</scope></search><sort><creationdate>20140428</creationdate><title>Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients</title><author>Antoniou, Alexander J. ; Marcus, Charles ; Tahari, Abdel K. ; Wahl, Richard L. ; Subramaniam, Rathan M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j1640-1495ea891ebcad486d6955e1fed49691ff8d81c3bd23d973a047e20dac97580b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; jpn</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Antoniou, Alexander J.</creatorcontrib><creatorcontrib>Marcus, Charles</creatorcontrib><creatorcontrib>Tahari, Abdel K.</creatorcontrib><creatorcontrib>Wahl, Richard L.</creatorcontrib><creatorcontrib>Subramaniam, Rathan M.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of nuclear medicine (1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Antoniou, Alexander J.</au><au>Marcus, Charles</au><au>Tahari, Abdel K.</au><au>Wahl, Richard L.</au><au>Subramaniam, Rathan M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients</atitle><jtitle>The Journal of nuclear medicine (1978)</jtitle><date>2014-04-28</date><risdate>2014</risdate><volume>55</volume><issue>7</issue><spage>1062</spage><epage>1068</epage><pages>1062-1068</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><abstract>The value of performing follow-up PET/CT imaging more than 6 mo after the conclusion of therapy—either as a routine practice or because of clinically suspected recurrence—is not well established. The purpose of this study was to evaluate the added value of follow-up PET/CT to the clinical assessment and survival outcome of lung cancer patients.</abstract><pmid>24777290</pmid><doi>10.2967/jnumed.113.136770</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-5505
ispartof The Journal of nuclear medicine (1978), 2014-04, Vol.55 (7), p.1062-1068
issn 0161-5505
1535-5667
language eng ; jpn
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4324379
source EZB-FREE-00999 freely available EZB journals
title Follow-up or Surveillance 18F-FDG PET/CT and Survival Outcome in Lung Cancer Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A57%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Follow-up%20or%20Surveillance%2018F-FDG%20PET/CT%20and%20Survival%20Outcome%20in%20Lung%20Cancer%20Patients&rft.jtitle=The%20Journal%20of%20nuclear%20medicine%20(1978)&rft.au=Antoniou,%20Alexander%20J.&rft.date=2014-04-28&rft.volume=55&rft.issue=7&rft.spage=1062&rft.epage=1068&rft.pages=1062-1068&rft.issn=0161-5505&rft.eissn=1535-5667&rft_id=info:doi/10.2967/jnumed.113.136770&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4324379%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24777290&rfr_iscdi=true